Publications by authors named "P Secchiero"
This study evaluated ethosomes as a novel nanodelivery system for nutlin-3a, a known MDM2 inhibitor and activator of the p53 pathway, to improve nutlin-3a's poor solubility, limiting its bio-distribution and therapeutic efficacy. The potential of nutlin-3a-loaded ethosomes was investigated on two in vitro models of melanoma: the HT144 cell line p53 and the SK-MEL-28 cell line p53. Nutlin-3a-loaded ethosomes were characterized for their physicochemical properties and used to treat melanoma cells at different concentrations, considering nutlin-3a solution and empty ethosomes as controls.
View Article and Find Full Text PDFMultiple sclerosis (MS) is a chronic inflammatory neurodegenerative disease leading to progressive demyelination and neuronal loss, with extensive neurological symptoms. As one of the most widespread neurodegenerative disorders, with an age onset of about 30 years, it turns out to be a socio-health and economic issue, thus necessitating therapeutic interventions currently unavailable. Loss of integrity in the blood-brain barrier (BBB) is one of the distinct MS hallmarks.
View Article and Find Full Text PDFArticle Synopsis
- The incidence of metabolic syndrome (MS) has risen in developed countries due to lifestyle choices, combining various health issues that heighten the risk of diabetes and heart diseases.
- Chronic low-grade inflammation, largely driven by obesity and an increase in visceral fat, plays a vital role in the development of MS and is now recognized as a significant cardiovascular risk factor.
- Psoriasis, an inflammatory skin condition, may be linked to metabolic disorders; improving diet and exercise can enhance psoriasis treatment outcomes, highlighting the potential of gut microbiota as a target for therapeutic interventions.
Research progresses have led to the development of different kinds of nanoplatforms to deliver drugs through different biological membranes. Particularly, nanocarriers represent a precious means to treat skin pathologies, due to their capability to solubilize lipophilic and hydrophilic drugs, to control their release, and to promote their permeation through the stratum corneum barrier. A crucial point in the development of nano-delivery systems relies on their characterization, as well as in the assessment of their interaction with tissues, in order to predict their fate under in vivo administration.
View Article and Find Full Text PDFPurpose: Proliferative vitreoretinal diseases (PVDs) represent a heterogeneous group of pathologies characterized by the presence of retinal proliferative membranes, in whose development retinal pigment epithelium (RPE) is deeply involved. As the only effective treatment for PVDs at present is surgery, we aimed to investigate the potential therapeutic activity of Nutlin-3a, a small non-genotoxic inhibitor of the MDM2/p53 interaction, on ARPE-19 cell line and on human RPE primary cells, as in vitro models of RPE and, more importantly, to formulate and evaluate Nutlin-3a loaded liposomes designed for ophthalmic administration.
Methods: Liposomes were produced using an innovative approach by a microfluidic device under selection of different conditions.